Click Here To View
Latest Type 1 Issues Articles
Popular Type 1 Issues Articles
Highly Recommended Type 1 Issues Articles
Send a link to this page to your friends and colleagues.
Xilas Medical, Inc., of San Antonio, Texas, has announced that its TempTouch home infrared temperature probe is now available to consumers who have been diagnosed with diabetes and are susceptible to foot-related problems.
The TempTouch measures and monitors human skin surface temperature. The handheld monitoring device is portable and noninvasive.
“Now consumers can be empowered to monitor their own temperature and take another step in the management of their disease,” says Don Lawson, CEO of Xilas Medical. “Our goal is to prevent diabetes-related amputations, which are a significant development for the millions of people who are affected.”
Lawson adds that many diabetics lose sensation in their feet, which makes it difficult for them to feel inflammation or the beginnings of an ulcer. The TempTouch is a way for them to easily test for potential problems and take action to prevent complications.
Xilas says that the TempTouch was clinically tested in two trials sponsored by the National Institutes of Health, and the studies found a 10-fold reduction in foot ulcers for people using the device.
In the United States, the TempTouch sells for $150 plus $14.95 for shipping and handling.
The device requires a doctor’s prescription. Consumers can obtain the necessary form by logging on to www.xilas.com/order. The completed form can be sent by fax to Xilas’s order department at (210) 692-1144.
For more information, call (210) 692-1114.
Source: Xilas Medical, Inc.